[SLN] QoQ Quarter Result on 31-Mar-2017 [#Q1]

Stock
[SLN] Silence Therapeutics plc
Announcement Date
30-Mar-2017
Financial Year
2017
Quarter
31-Mar-2017 [#Q1]
Profit Trend
QoQ- -48.76%
YoY- -16.52%
Quarter Report
SLN's Result
SLN's Financial Summary
View:
Show?
Quarter Result
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
Revenue 0 0 8 8 385 385 0 -
PBT 1,441 1,441 -3,328 -3,328 -2,410 -2,410 -2,771 -
Tax 508 508 570 570 557 557 405 16.25%
NP 1,949 1,949 -2,758 -2,758 -1,854 -1,854 -2,367 -
Tax Rate -35.30% -35.30% - - - - - -
Total Cost -1,949 -1,949 2,766 2,766 2,239 2,239 2,367 -
Ratio Analysis
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
NP Margin 0.00 0.00 -34,475.00 -34,475.00 -481.43 -481.43 0.00 -
Per Share
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
EPS 0.08 0.08 -0.12 -0.12 -0.08 -0.08 -0.10 -
EPS Diluted 0.08 0.08 -0.12 -0.12 -0.08 -0.08 -0.10 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.